Talphera Net Income

TLPH Stock   0.81  0.02  2.53%   
As of the 8th of February, Talphera has the Variance of 28.7, risk adjusted performance of (0.1), and Coefficient Of Variation of (773.64). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Talphera, as well as the relationship between them.

Talphera Total Revenue

0.0

Talphera's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Talphera's valuation are provided below:
Gross Profit
-5.8 M
Market Capitalization
37.9 M
Enterprise Value Revenue
597.1837
Revenue
28 K
Earnings Share
(0.38)
We have found one hundred twenty available fundamental trend indicators for Talphera, which can be analyzed and compared to other ratios and to its competition. Traders should compare all of Talphera current fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 14.8 M. Enterprise Value is estimated to decrease to about 12.2 M This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-15 M-15.7 M
Net Loss-15 M-15.7 M
Net Loss(0.45)(0.48)
Net Income Per E B T 1.61  0.94 
The current Net Loss is estimated to decrease to about (15.7 M). The current Net Loss is estimated to decrease to about (15.7 M).
  
Build AI portfolio with Talphera Stock
The Net Income trend for Talphera offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Talphera is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Talphera's Net Income Growth Pattern

Below is the plot of the Net Income of Talphera over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Talphera financial statement analysis. It represents the amount of money remaining after all of Talphera operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Talphera's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Talphera's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (13 M)10 Years Trend
Pretty Stable
   Net Income   
       Timeline  

Talphera Net Income Regression Statistics

Arithmetic Mean(25,549,819)
Geometric Mean27,122,135
Coefficient Of Variation(87.46)
Mean Deviation15,629,346
Median(24,399,000)
Standard Deviation22,346,301
Sample Variance499.4T
Range95.8M
R-Value0.23
Mean Square Error505.2T
R-Squared0.05
Significance0.38
Slope1,004,758
Total Sum of Squares7989.7T

Talphera Net Income History

2026-15.7 M
2025-15 M
2024-13 M
2023-18.4 M
202242.5 M
2021-35.1 M
2020-40.4 M

Other Fundumenentals of Talphera

Talphera Net Income component correlations

Talphera Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Talphera is extremely important. It helps to project a fair market value of Talphera Stock properly, considering its historical fundamentals such as Net Income. Since Talphera's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Talphera's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Talphera's interrelated accounts and indicators.
Is there potential for Pharmaceuticals market expansion? Will Talphera introduce new products? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.38)
Revenue Per Share
0.001
Return On Assets
(0.31)
Return On Equity
(0.86)
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Talphera's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Talphera 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Talphera's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Talphera.
0.00
11/10/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/08/2026
0.00
If you would invest  0.00  in Talphera on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Talphera or generate 0.0% return on investment in Talphera over 90 days. Talphera is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. Teliphone Corporation, a telecommunications company, offer voice, data, and cloud services in Canada. More

Talphera Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Talphera's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Talphera upside and downside potential and time the market with a certain degree of confidence.

Talphera Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Talphera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Talphera's standard deviation. In reality, there are many statistical measures that can use Talphera historical prices to predict the future Talphera's volatility.
Hype
Prediction
LowEstimatedHigh
0.040.796.01
Details
Intrinsic
Valuation
LowRealHigh
0.071.426.64
Details
2 Analysts
Consensus
LowTargetHigh
2.963.253.61
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.09-0.09-0.09
Details

Talphera February 8, 2026 Technical Indicators

Talphera Backtested Returns

Talphera owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Talphera exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Talphera's Coefficient Of Variation of (773.64), variance of 28.7, and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide. The entity has a beta of 0.34, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Talphera's returns are expected to increase less than the market. However, during the bear market, the loss of holding Talphera is expected to be smaller as well. At this point, Talphera has a negative expected return of -0.59%. Please make sure to validate Talphera's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Talphera performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.59  

Modest predictability

Talphera has modest predictability. Overlapping area represents the amount of predictability between Talphera time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Talphera price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Talphera price fluctuation can be explain by its past prices.
Correlation Coefficient0.59
Spearman Rank Test0.57
Residual Average0.0
Price Variance0.01
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Talphera Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

4,228.57

As of now, Talphera's Accumulated Other Comprehensive Income is decreasing as compared to previous years.
Based on the recorded statements, Talphera reported net income of (13 Million). This is 103.81% lower than that of the Pharmaceuticals sector and 96.62% lower than that of the Health Care industry. The net income for all United States stocks is 102.28% higher than that of the company.

Talphera Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Talphera's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Talphera could also be used in its relative valuation, which is a method of valuing Talphera by comparing valuation metrics of similar companies.
Talphera is currently under evaluation in net income category among its peers.

Talphera Fundamentals

About Talphera Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Talphera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talphera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talphera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Talphera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Talphera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Talphera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Talphera Stock:
Check out
For more detail on how to invest in Talphera Stock please use our How to Invest in Talphera guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is there potential for Pharmaceuticals market expansion? Will Talphera introduce new products? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.38)
Revenue Per Share
0.001
Return On Assets
(0.31)
Return On Equity
(0.86)
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Talphera's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.